David E. Jane
Impact in
- Cellular and Molecular Neuroscience top 0.05%
- Neuroscience and Neuropharmacology Research
- Psychiatry and Mental health top 5%
- Epilepsy research and treatment
- Schizophrenia research and treatment
Papers in
-
- Neuroscience and Neuropharmacology Research 115
-
- Epilepsy research and treatment 4
- Co-authors
- Graham L. Collingridge (38 shared papers)Darryle D. Schoepp (2 shared papers)James A. Monn (1 shared paper)J. C. Watkins (15 shared papers)Heong‐Wai Tse (18 shared papers)Daniel T. Monaghan (27 shared papers)Zuner Assis Bortolotto (18 shared papers)J.C. Watkins (10 shared papers)
- Journals
- Neuropharmacology (37 papers)British Journal of Pharmacology (16 papers)Journal of Medicinal Chemistry (10 papers)European Journal of Pharmacology (6 papers)Journal of Neuroscience (5 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
David E. Jane
139 papers receiving 8.4k citations
David E. Jane's Hit Papers
Peers
Comparison fields: 5 of 88
- Cellular and Molecular Neuroscience 5.1k
- Psychiatry and Mental health 383
- Biological Psychiatry 19
- Developmental Neuroscience 42
- Physiology 364
Countries citing papers authored by David E. Jane
This map shows the geographic impact of David E. Jane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Jane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Jane more than expected).
Fields of papers citing papers by David E. Jane
This network shows the impact of papers produced by David E. Jane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Jane. The network helps show where David E. Jane may publish in the future.
Co-authors
The 25 scholars most cited alongside David E. Jane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 140 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pharmacological agents acting at subtypes of metabotropic glutamate receptors Hit paper breakdown → | 1999 | 958 |
| 2 | 1993 | 650 | |
| 3 | 1997 | 295 | |
| 4 | 1997 | 286 | |
| 5 | 2008 | 225 | |
| 6 | 2006 | 223 | |
| 7 | 1993 | 206 | |
| 8 | 2015 | 206 | |
| 9 | 2012 | 205 | |
| 10 | 1987 | 204 | |
| 11 | 1994 | 173 | |
| 12 | 1993 | 138 | |
| 13 | 2001 | 131 | |
| 14 | 1996 | 125 | |
| 15 | 2004 | 123 | |
| 16 | 1993 | 117 | |
| 17 | 2000 | 116 | |
| 18 | 2013 | 110 | |
| 19 | 2008 | 104 | |
| 20 | 1995 | 98 |
About David E. Jane
David E. Jane is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health, Molecular Biology, Polymers and Plastics and Pharmacology, having authored 140 papers that have together received 8.8k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (115 papers), Epilepsy research and treatment (4 papers), Ion channel regulation and function (3 papers), Receptor Mechanisms and Signaling (1 paper), Memory and Neural Mechanisms (1 paper), Genetics and Neurodevelopmental Disorders (1 paper), Organophosphorus compounds synthesis (1 paper) and Protein Structure and Dynamics (1 paper). The work is most often cited by research in Cellular and Molecular Neuroscience (5.1k citations), Psychiatry and Mental health (383 citations), Biological Psychiatry (19 citations), Developmental Neuroscience (42 citations) and Physiology (364 citations). David E. Jane has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Graham L. Collingridge, Darryle D. Schoepp, James A. Monn, J. C. Watkins, Heong‐Wai Tse, Daniel T. Monaghan, Zuner Assis Bortolotto, J.C. Watkins, Jeremy Martin Henley and Andrew J. Irving. Their work appears in journals such as Neuropharmacology, British Journal of Pharmacology, Journal of Medicinal Chemistry, European Journal of Pharmacology and Journal of Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.